ALS precursor finally shaken into fibrils

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 48, 2008, Pages 18649-18650

  Rousseau, Frederic ^a   Schymkowitz, Joost ^a   Oliveberg, Mikael ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; CYSTEINE; MUTANT PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CROSS LINKING; CYTOTOXICITY; ENZYME STABILITY; ENZYME STRUCTURE; HUMAN; HYDROPHILICITY; MUTATION; NERVE CELL; NEUROFILAMENT; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; INCLUSION BODIES; MODELS, MOLECULAR; NEURONS; PROTEIN CONFORMATION; PROTEIN PRECURSORS; SUPEROXIDE DISMUTASE;

EID: 57749101297     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0810568106     Document Type: Note

References (20)

1. Stathopulos PB, et al. (2003) Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro. Proc Natl Acad Sci USA 100:7021-7026.
2. DiDonato M, et al. (2003) ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J Mol Biol 332:601-615.
3. Banci L, et al. (2008) SOD1 and amyotrophic lateral sclerosis: Mutations and oligomerization. PLoS ONE 3:e1677.
4. Linding R, Schymkowitz J, Rousseau F, Diella F, Serrano L (2004) A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J Mol Biol 342:345-353.
5. Chattopadhyay M, et al. (2008) Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc Natl Acad Sci USA 105:18663-18668.
6. Furukawa Y, Kaneko K, Yamanaka K, O'Halloran TV, Nukina N (2008) Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in familial form of amyotrophic lateral sclerosis. J Biol Chem 283:24167-24176.
7. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333-366.
8. Lindberg MJ, Bystrom R, Boknas N, Andersen PM, Oliveberg M (2005) Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. Proc Natl Acad Sci USA 102:9754-9759.
9. Sandelin E, Nordlund A, Andersen PM, Marklund SS, Oliveberg M (2007) Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins. J Biol Chem 282:21230-21236.
10. Rousseau F, Serrano L, Schymkowitz JW (2006) How evolutionary pressure against protein aggregation shaped chaperone specificity. J Mol Biol 355:1037-1047.
11. Rousseau F, Schymkowitz J, Serrano L (2006) Protein aggregation and amyloidosis: Confusion of the kinds? Curr Opin Struct Biol 16:118-126.
12. Niwa J, et al. (2007) Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. J Biol Chem 282:28087-28095.
13. Jonsson PA, et al. (2006) Disulfide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain 129:451-464.
14. Zetterstrom P, et al. (2007) Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proc Natl Acad Sci USA 104:14157-14162.
15. Estevez AG, et al. (1999) Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286:2498-2500.
16. Okado-Matsumoto A, Fridovich I (2002) Amyotrophic lateral sclerosis:Aproposed mechanism. Proc Natl Acad Sci USA 99:9010-9014.
17. Walsh DM, Selkoe DJ (2007) Aβ oligomers - a decade of discovery. J Neurochem 101:1172-1184.
18. Shankar GM, et al. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14:837-842.
19. Otzen DE, Oliveberg M (2004) Transient formation of nano-crystalline structures during fibrillation of an Aβ-like peptide. Protein Sci 13:1417-1421.
20. Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A (2006) Opposing activities protect against age-onset proteotoxicity. Science 313:1604-1610.